| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEO | Common Stock | Options Exercise | $0 | +6,502 | +19% | $0.000000 | 40,998 | 11 May 2024 | Direct | F1 |
| transaction | NEO | Common Stock | Tax liability | $23,538 | -1,584 | -3.9% | $14.86 | 39,414 | 11 May 2024 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEO | Restricted Stock Unit | Options Exercise | $0 | -6,502 | -33% | $0.000000 | 13,006 | 11 May 2024 | Common Stock | 6,502 | $0.000000 | Direct | F4, F5 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. |
| F2 | Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| F3 | On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares received upon the vesting of certain of her RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 39,414 shares of common stock after the vesting of 6,502 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4. |
| F4 | On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. |
| F5 | Once vested, the shares of common stock are not subject to expiration. |